Taysha Gene Therapies
TSHA
TSHA
148 hedge funds and large institutions have $595M invested in Taysha Gene Therapies in 2025 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+23
Holders Change %
+18.4%
% of All Funds
1.98%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
44
Increased
48
Reduced
33
Closed
20
Calls
$465K
Puts
$47K
Net Calls
+$418K
Net Calls Change
+$281K
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$54.4M |
| 2 |
Goldman Sachs
New York
|
$29.1M |
| 3 |
JFG
Jefferies Financial Group
New York
|
$23.8M |
| 4 |
RI
RTW Investments
New York
|
$57.8M |
| 5 |
DM
Deerfield Management
New York
|
$12.4M |
